| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |